OrsoBio

Menlo Park, CA · Founded 2020 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to develop therapies for organ dysfunction. OrsoBio is based in Menlo Park, CA and was founded in 2020. Its last known valuation is $310 million. It has raised $167 million across 2 recorded rounds; the latest was a $40 million early-stage round in Aug 2024.

Last price · $/share
—
Implied valuation
$310.0M
Total raised
$166.6M
Last round
Early Stage VC
Aug 2024
How much has OrsoBio raised?
$166.6Macross 2 recorded rounds · Oct 2023 – Aug 2024

Most recently, OrsoBio raised $40.0M in its Early Stage VC (Aug 2024).

Free account
More of OrsoBio with a free account
  • ·Watch OrsoBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OrsoBio round by round

2 rounds
Aug 2024Early Stage VC$40.0MSEC filing▮
7 investors participated
Oct 2023Later Stage VC$84.6MSEC filing▮
6 investors participated

How much has OrsoBio raised?

OrsoBio has raised $167 million in total; 2 of its rounds are on record. The largest on record was an $84.6 million later-stage round in Oct 2023; the most recent was a $40 million early-stage round in Aug 2024.

OrsoBio has filed 2 Form Ds with the SEC since 2023, most recently in Aug 2024 ($40 million sold to 7 investors).

OrsoBio investors

8 investors are on record for OrsoBio, including Samsara BioCapital, Longitude Capital, Woodline Partners and Ascenta Capital. The early-stage round in Aug 2024 drew 7 investors.

For fundraisers
Raising for a company like OrsoBio?

8 investors have backed OrsoBio.

See all 8 investors →

Frequently asked about OrsoBio

How much has OrsoBio raised?
OrsoBio has raised $166.6M in total across 2 recorded funding rounds.
When was OrsoBio's last funding round?
OrsoBio's most recent recorded round was Early Stage VC in Aug 2024, raising $40.0M.